Literature DB >> 10413831

The complement system: pathophysiology and clinical relevance.

C Speth1, R Würzner, H Stoiber, M P Dierich.   

Abstract

In the present article we review selected aspects of the complement system as a major determinant of innate immunity. Besides a detailed description of the components of the complement system, its mode of action, cellular receptors and regulatory control mechanisms, we have focused on the role of the complement system in mutual defence strategies of invading viral pathogens and the host. Since a detrimental activation of the complement cascade is a critical element of several pathological conditions in diverse organs, we summarise the role of a deteriorated complement system in dermatology, nephrology, neurology and xenotransplantation.

Mesh:

Substances:

Year:  1999        PMID: 10413831

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  4 in total

1.  C5a-induced in vitro basophil activation in patients with chronic urticaria: a pilot study.

Authors:  Peter Korosec; Tjasa Subic; Katja Adamic; Mira Silar; Mitja Kosnik
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons.

Authors:  Cornelia Speth; Thomas Schabetsberger; Iradji Mohsenipour; Gabriele Stöckl; Reinhard Würzner; Heribert Stoiber; Cornelia Lass-Flörl; Manfred P Dierich
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes.

Authors:  C Speth; G Stöckl; I Mohsenipour; R Würzner; H Stoiber; C Lass-Flörl; M P Dierich
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis.

Authors:  Mia Furebring; Lena Douhan Håkansson; Per Venge; Bo Nilsson; Jan Sjölin
Journal:  Crit Care       Date:  2002-06-13       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.